Working… Menu

Evaluation of the Immune Restoration Potential Of Lenalidomide (Revlimid)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02371577
Recruitment Status : Withdrawn (withdrawn)
First Posted : February 25, 2015
Last Update Posted : April 28, 2017
Celgene Corporation
Information provided by (Responsible Party):
Michael Choi, University of California, San Diego

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2020